Skip to content


Frova (frovatriptan) is a small molecule pharmaceutical. Frovatriptan was first approved as Frova on 2001-11-08. It is used to treat migraine disorders in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 1B and 5-hydroxytryptamine receptor 1D. In addition, it is known to target 5-hydroxytryptamine receptor 1A.
Trade Name Frova
Common Name Frovatriptan
Indication migraine disorders
Drug Class Antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives
Get full access now